Vanda Pharmaceuticals reports Q1 2026 earnings results

Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read

Key Changes

• high

  Vanda released first quarter 2026 financial results via press release and held earnings conference call on May 6, 2026. Specific financial figures are contained in the attached press release.

  Item 7.01 view on EDGAR →
• low

  Company provided standard forward-looking statement disclosures covering commercial products, development pipeline, clinical timelines, and regulatory matters discussed during the earnings call.

  Item 7.01 view on EDGAR →